[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100521437":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":31,"locations":40,"responsibleParty":96,"collaborators":99,"id":108,"slug":109,"hasResults":110,"nctId":111,"briefTitle":112,"officialTitle":113,"acronym":25,"eligibilityCriteria":114,"healthyVolunteers":110,"sex":115,"minAge":116,"maxAge":25,"enrollmentInfo":117,"targetDuration":25,"studyType":120,"phases":121,"briefSummary":123,"conditions":124,"keywords":130,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":145},{"fullName":5,"class":6},"McGill University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Support integrated in usual care","EXPERIMENTAL","PWT1D participants will have access to Support as part of their regular care (their HCPs will use Support in their care). PWT1D participants in ARM 1 are followed in one of the 4 participating clinics either in-person or remotely or hybrid.",[13],"Behavioral: Support platform",{"label":15,"type":16,"description":17,"interventionNames":18},"Support through independent access","ACTIVE_COMPARATOR","PWT1D participants will have access to Support, independently from their regular care (they may initiate discussion about the platform with their diabetes care team who might register themselves on the platform, but will not prompt to any specific section on the platform and will not receive any training about the platform). PWT1D participants in ARM 2 can be followed in any other clinics in Canada.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Support platform","The study will be conducted over a 12-month period. This should allow participants to see their medical team 2 to 3 times during this timeframe. Participants of arms 1 and 2 will have access to the Support platform and will receive a monthly newsletter, informing them of news on the platform and acting as a reminder to log in. Several features are included in this responsive-designed platform to enhance participation, such as a visual of personal progress, ability to bookmark content, change their avatar.\n\nSupport contains 3 main components: Educational material, News blog written by HCPs weekly in collaboration with patient-partners on up-to-date topics related to T1D, a peer-to-peer discussion forum which is moderated daily by a HCP specializing in T1D.",[9,15],null,[27],{"name":28,"affiliation":29,"role":30},"Anne-Sophie Brazeau, PhD","School of human nutrition - McGill University","PRINCIPAL_INVESTIGATOR",[32,36],{"name":28,"role":33,"phone":34,"phoneExt":25,"email":35},"CONTACT","5143987848","anne-sophie.brazeau@mcgill.ca",{"name":37,"role":33,"phone":38,"phoneExt":25,"email":39},"amelie Roy-Fleming, MSc","5147790749","amelie.roy-fleming@mcgill.ca",[41,60,70,83],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Institut de recherches cliniques de Montréal","RECRUITING","Montreal","Quebec","H2W 1R7","Canada","CA",{"type":50,"coordinates":51},"Point",[52,53],-73.58781,45.50884,{"lat":53,"lon":52},[56],{"name":57,"role":33,"phone":58,"phoneExt":25,"email":59},"Marie Devaux","5149875500","type1support@mcgill.ca",{"facility":61,"status":43,"city":44,"state":45,"zip":62,"country":47,"countryCode":48,"cosmosGeoPoint":63,"geoPoint":65,"contacts":66},"Centre hospitalier de l'université de Montreal","H2X 0C1",{"type":50,"coordinates":64},[52,53],{"lat":53,"lon":52},[67],{"name":68,"role":33,"phone":69,"phoneExt":25,"email":59},"Ann Gobeil","514-890-8000",{"facility":71,"status":43,"city":72,"state":45,"zip":73,"country":47,"countryCode":48,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Centre hospitalier de Quebec, Université Laval","Québec","G1V 0E8",{"type":50,"coordinates":75},[76,77],-71.21454,46.81228,{"lat":77,"lon":76},[80],{"name":81,"role":33,"phone":82,"phoneExt":25,"email":59},"Claudia Huard","418-525-4444",{"facility":84,"status":43,"city":85,"state":45,"zip":86,"country":47,"countryCode":48,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Centre de médecine métabolique de Lanaudière","Terrebonne","J6x 4P7",{"type":50,"coordinates":88},[89,90],-73.64732,45.70004,{"lat":90,"lon":89},[93],{"name":94,"role":33,"phone":95,"phoneExt":25,"email":59},"Tammy Cadieux","514-907-5101",{"type":30,"investigatorFullName":97,"investigatorTitle":98,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Anne-Sophie Brazeau","Associate Professor",[100,102,104,106],{"name":101,"class":6},"Institut de Recherches Cliniques de Montreal",{"name":103,"class":6},"Centre de Recheche du Centre Hospitalier Université Laval",{"name":105,"class":6},"Centre hospitalier de l'Université de Montréal (CHUM)",{"name":84,"class":107},"UNKNOWN","100521437","implementation-of-support-in-the-care-of-adults-living-with-type-1-diabetes-100521437",false,"NCT06069583","Implementation of Support in the Care of Adults Living With Type 1 Diabetes","Using the Support Online Platform for Self-management Education of Adults Living With Type 1 Diabetes as Part of Usual Care or Independently: an Implementation Study","Inclusion Criteria:\n\n* Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)\n* Have access to Internet\n* Use of an active email address\n* Comprehension of English or French\n* Live in Canada\n\nExclusion Criteria:\n\n\\- Unable to use the Support platform","ALL","18 Years",{"count":118,"type":119},322,"ESTIMATED","INTERVENTIONAL",[122],"NA","The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the \"Support\" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration \"Support\" in clinical care.",[125,126,127,128,129],"Type 1 Diabetes","Metabolic Disease","Endocrine System Diseases","Autoimmune Diseases","Immune System Diseases",[131,132,133,134,135],"self-management education","Hemaglobin A1c","Online education","adults","type 1 diabetes","2025-09-22",{"date":138,"type":139},"2025-09-25","ACTUAL",{"date":141,"type":139},"2024-05-05",{"date":143,"type":119},"2027-10",{"name":5,"class":6},4]